Screener
Axsome Therapeutics AXSM Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Goodwill | 12,042 | 12,042 |
| Intangible asset, net | 38,947 | 40,519 |
| Non-current inventory and other assets | 30,831 | 26,838 |
| Total assets | $713,607 | $689,805 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $106,702 | $65,537 |
| Accrued expenses and other current liabilities | 250,731 | 232,853 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Axsome Therapeutics's total assets?
- Axsome Therapeutics (AXSM) reported total assets of $713.61M in Q1 2026.
- How has Axsome Therapeutics's total assets changed year-over-year?
- Axsome Therapeutics's total assets increased by 19.6% year-over-year, from $596.67M to $713.61M.
- What is the long-term trend for Axsome Therapeutics's total assets?
- Over 5 years (2020 to 2025), Axsome Therapeutics's total assets has grown at a 30.0% compound annual growth rate (CAGR), from $186.13M to $689.81M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Axsome Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude